About 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid
1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid (PubChem CID 135149550) has the molecular formula C47H53N9O9S2
and a molecular weight of 952.13 g/mol. Its IUPAC name is 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid.
Molecular Properties
| Compound Name | 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid |
| PubChem CID | 135149550 |
| Molecular Formula | C47H53N9O9S2 |
| Molecular Weight | 952.13 g/mol |
| Exact Mass | 951.34 |
| IUPAC Name | 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid |
| SMILES | COc1ccc(CN(Cc2ccc(OC)cc2)S(=O)(=O)c2c(S(=O)(=O)CC(C)N(C(=O)O)C(C)(C)C)ccc(-c3cccc4c3nc(N)n4C)c2-c2nnn(Cc3ccc(OC)cc3)n2)cc1 |
| InChI | InChI=1S/C47H53N9O9S2/c1-30(56(46(57)58)47(2,3)4)29-66(59,60)40-25-24-37(38-10-9-11-39-42(38)49-45(48)53(39)5)41(44-50-52-55(51-44)28-33-16-22-36(65-8)23-17-33)43(40)67(61,62)54(26-31-12-18-34(63-6)19-13-31)27-32-14-20-35(64-7)21-15-32/h9-25,30H,26-29H2,1-8H3,(H2,48,49)(H,57,58) |
| InChIKey | MJJOMNDPIJQHCP-UHFFFAOYSA-N |
| XLogP | 6.88 |
| TPSA | 227.19 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 67 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
| MW ≤ 500 | 952.13 |
| LogP ≤ 5 | 6.88 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 15 |
Analyze 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid?
The IUPAC name of 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid (CID 135149550) is 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid.
What is the SMILES notation for 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid?
The canonical SMILES for 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid is COc1ccc(CN(Cc2ccc(OC)cc2)S(=O)(=O)c2c(S(=O)(=O)CC(C)N(C(=O)O)C(C)(C)C)ccc(-c3cccc4c3nc(N)n4C)c2-c2nnn(Cc3ccc(OC)cc3)n2)cc1.
What is the InChIKey of 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid?
The InChIKey is MJJOMNDPIJQHCP-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H53N9O9S2/c1-30(56(46(57)58)47(2,3)4)29-66(59,60)40-25-24-37(38-10-9-11-39-42(38)49-45(48)53(39)5)41(44-50-52-55(51-44)28-33-16-22-36(65-8)23-17-33)43(40)67(61,62)54(26-31-12-18-34(63-6)19-13-31)27-32-14-20-35(64-7)21-15-32/h9-25,30H,26-29H2,1-8H3,(H2,48,49)(H,57,58).
What are the key properties of 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid?
1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid has a molecular weight of 952.13 g/mol, XLogP of 6.88, 17 rotatable bonds, 2 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[4-(2-amino-1-methylbenzimidazol-4-yl)-2-[bis[(4-methoxyphenyl)methyl]sulfamoyl]-3-[2-[(4-methoxyphenyl)methyl]tetrazol-5-yl]phenyl]sulfonylpropan-2-yl-tert-butylcarbamic acid is sourced from PubChem (CID 135149550), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).